Valuation North China Pharmaceutical Company.Ltd

Stocks

End-of-day quote Shanghai S.E. 2026-11-02			5-day change	1st Jan Change
4.660 ^CNY	+2.42%		-2.71%	-15.73%

10-27	North China Pharmaceutical Company.Ltd Reports Earnings Results for the Nine Months Ended September 30, 2026	CI
09-21	North China Pharmaceutical Company.Ltd(XSSC:600812) dropped from FTSE All-World Index	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	16,781	20,452	10,981	9,780	8,870	9,488
Change	-	21.87%	-46.31%	-10.94%	-9.3%	6.96%
Enterprise Value (EV) ¹	25,126	28,923	20,346	19,939	18,660	19,162
Change	-	15.11%	-29.65%	-2%	-6.41%	2.69%
P/E	172x	1,084x	-15.9x	1,900x	69.9x	51.7x
PBR	2.74x	3.36x	2.07x	1.84x	1.65x	1.72x
PEG	-	-13.3x	0x	-19x	0x	1.2x
Capitalization / Revenue	1.46x	1.97x	1.05x	0.97x	0.9x	1.03x
EV / Revenue	2.19x	2.79x	1.94x	1.97x	1.89x	2.07x
EV / EBITDA	20.8x	23.7x	15.2x	15.7x	12.9x	12.6x
EV / EBIT	42x	48.2x	32.1x	37.2x	28.3x	30.6x
EV / FCF	-30.9x	-32x	112x	128x	49.1x	35.2x
FCF Yield	-3.24%	-3.12%	0.89%	0.78%	2.03%	2.84%
Dividend per Share ²	0.03	0.06	-	0.01	0.03	0.035
Rate of return	0.29%	0.5%	-	0.18%	0.58%	0.63%
EPS ²	0.06	0.011	-0.402	0.003	0.074	0.107
Distribution rate	50%	545%	-	333%	40.5%	32.7%
Net sales ¹	11,493	10,385	10,500	10,120	9,870	9,242
EBITDA ¹	1,209	1,221	1,343	1,272	1,447	1,517
EBIT ¹	597.9	600.1	634.8	536.4	658.9	627.2
Net income ¹	97.32	18.73	-689.2	4.89	127	183.1
Net Debt ¹	8,345	8,472	9,366	10,159	9,790	9,674
Reference price ²	10.290	11.920	6.400	5.700	5.170	5.530
Nbr of stocks (in thousands)	1,630,805	1,715,730	1,715,730	1,715,730	1,715,730	1,715,730
Announcement Date	4/28/21	4/27/22	4/21/23	3/29/24	3/27/25	4/17/26

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
NORTH CHINA PHARMACEUTICAL COMPANY.LTD	-	-	-	-	1.2B
ELI LILLY AND COMPANY	41.24x	13.98x	31x	0.48%	1,257B
JOHNSON & JOHNSON	39.6x	6.65x	18.71x	1.97%	651B
ABBVIE INC.	36.2x	8.44x	17.42x	2.4%	510B
ROCHE HOLDING AG	21.41x	5.2x	12.95x	2.52%	388B
MERCK & CO., INC.	98.19x	6.02x	25.62x	2.29%	366B
NOVARTIS AG	22.92x	5.89x	14.21x	2.72%	303B
ASTRAZENECA PLC	24.43x	4.89x	13.76x	1.79%	288B
AMGEN INC.	29.52x	7.52x	13.46x	2.17%	252B
GILEAD SCIENCES, INC.	-40.78x	7.43x	46.67x	1.94%	211B
Average	30.30x	7.34x	21.53x	2.03%	422.79B
Weighted average by Cap.	36.23x	8.78x	22.70x	1.71%